Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
02/06/2003 | WO2003010120A1 Indane compounds with negative dielectric anisotropy |
02/06/2003 | WO2003009839A1 Benzofuranes and their use in the treatment of atrial fibrillation |
02/06/2003 | WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
02/06/2003 | WO2002078605A3 Premixed amiodarone parenteral solution and method for making the same |
02/06/2003 | WO2002071718A3 A method and system for a low-overhead mobility management protocol in the internet protocol layer |
02/06/2003 | WO2002070516A3 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
02/06/2003 | WO2002066418A3 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
02/06/2003 | US20030028036 Cyclooxygenase-2 (COX-2); preparing 4-(4-alkylsulfonyl-phenyl)-2,5-dihydro-furan-2-ones by reacting 2-alkoxy-2-(4-alkylsulfonylphenyl)oxetane with a substituted carboxylic acid and then cyclizing that product |
02/06/2003 | US20030027862 Amino-and amido-diphenyl ethers |
02/06/2003 | US20030027855 Preparation of a derivative or analog of baccatin III or 10-desacetyl baccatin III having a C9 hydroxy substituent by selective reduction of the C9 keto compound |
02/06/2003 | US20030027847 Carboxyformylacetamide derivatives for treatment of AIDS or ARC |
02/06/2003 | US20030027840 Estrogen receptor modulators |
02/06/2003 | US20030027830 Administering to a cancer patient an effective amount of chalcone or its derivaties to treat the tumor/cancer |
02/06/2003 | US20030027828 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use |
02/06/2003 | US20030027826 Useful for treating atherosclerosis and other coronary artery disease;reacting an amine compound with an epoxide derivative in presence of transition metal salt catalyst |
02/06/2003 | US20030027063 Apparatus and materials for three-dimensional optical data storage and retrieval |
02/06/2003 | US20030026521 Optical interleaver |
02/06/2003 | CA2453587A1 Benzofuranes and their use in the treatment of atrial fibrillation |
02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
02/05/2003 | EP1281709A1 Novel heterocyclic compounds with anti-inflammatory activity |
02/05/2003 | EP1281708A1 Process for the preparation of 5-Formylphthalide |
02/05/2003 | EP1281707A1 Process for the preparation of 5-subtituted isobenzofurans |
02/05/2003 | EP1280791A1 N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
02/05/2003 | EP1280788A1 Method for the production of l-ascorbic acid by lactonisation of 2-keto-l-gulonic acid or 2-keto-l-gulonate esters |
02/05/2003 | EP1280787A1 Method for distillative separation of mixtures containing tetrahydrofuran, $g(g)-butyrolactone and/or 1,4-butanediol |
02/05/2003 | EP1280770A1 C 2? phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
02/05/2003 | EP1280764A2 Inhibitors of histone deacetylase |
02/05/2003 | EP1280757A2 New gamma selective retinoids |
02/05/2003 | EP1280555A2 Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
02/05/2003 | CN1395572A Method for obtaining 2-bromo-5-(2-bromo-2-nitrovinyl)-furan |
02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
02/05/2003 | CN1394856A Process and formula for synthesizing L-ascorbyl palmitate |
02/05/2003 | CN1100774C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
02/05/2003 | CN1100773C Benzofran carboxamides and sulphonamides |
02/05/2003 | CN1100772C Process for hydrogenating dihydrofuranes to tetrahydrofuranes |
02/05/2003 | CN1100755C Aminophenyl ketone derivative and preparation method thereof |
02/05/2003 | CN1100610C Improved Ru, Re/carbon catalyst forhydrogenation in aqueous solution |
02/04/2003 | US6515148 Reacting a olefin and acid in presence of catalyst |
02/04/2003 | US6515147 Chemical intermediates for 2-butyl-5-nitrobenzofuran |
02/04/2003 | US6515146 Process for the oxidation of a hydrocarbon substrate containing at least 20% by volume of an inert gas to a corresponding oxidized hydrocarbon compound by contacting the hydrocarbon substrate with an oxygen containing atmosphere in |
02/04/2003 | US6515137 Enantioselectivity of alpha,beta-unsaturated aldehydes |
02/04/2003 | US6515124 Dehydroamino acids |
02/04/2003 | US6515021 The compounds according to the invention have pronounced activity in the fields of cell differentiation and cell proliferation |
02/04/2003 | US6515015 Antidiabetic agents based on aryl and heteroarylacetic acids |
02/04/2003 | US6514996 Phosphodiesterase (PDE) IV inhibitors; used to treat inflammatory allergic diseases, autoimmune diseases, diseases of the central nervous system, insulin-resistant diabetes; wounds; AIDS, and the like. |
02/04/2003 | US6514434 Electro-optic chromophore bridge compounds and donor-bridge compounds for polymeric thin film waveguides |
01/31/2003 | WO2002012169A1 Amino diphenyl ethers and amido diphenyl ethers |
01/31/2003 | CA2417880A1 Amino diphenyl ethers and amido diphenyl ethers |
01/30/2003 | WO2003008372A1 Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient |
01/30/2003 | WO2003008371A1 Substituted 4-aminocyclohexanol derivatives |
01/30/2003 | WO2003008370A1 Substituted 4-aminocyclohexanols |
01/30/2003 | WO2003008368A1 Process and intermediates to prepare latanoprost |
01/30/2003 | WO2003007931A1 Sulfonamide derivatives |
01/30/2003 | WO2003007872A2 Process for the preparation of citalopram hydrobromide |
01/30/2003 | WO2002055136A3 Intrasvascular drug delivery device and use therefor |
01/30/2003 | WO2002006267A3 Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a |
01/30/2003 | US20030023092 Reacting tetrahydrofuran compound with oxophilic electrophilic reagent to produce oxazoline compound |
01/30/2003 | US20030022931 Alkylxanthates and use of alkylxanthates in the integrated pest management |
01/30/2003 | US20030022893 Hydroxamic and carboxylic acid derivatives |
01/30/2003 | US20030022865 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
01/30/2003 | CA2454335A1 Process for the preparation of citalopram hydrobromide |
01/30/2003 | CA2453631A1 Process and intermediates to prepare latanoprost |
01/29/2003 | EP1279729A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors |
01/29/2003 | EP1279657A2 Process for preparing carbonyl compounds from alcohols |
01/29/2003 | EP1279656A2 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles |
01/29/2003 | EP1278752A1 Improved synthesis of anhydroglycitol esters of improved colour |
01/29/2003 | EP1278740A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
01/29/2003 | EP1278737A2 Process and intermediates for making substituted aspartic acid acetals |
01/29/2003 | EP1278722A1 Aryl and heteroaryl sulfonates |
01/29/2003 | EP1278711A1 Process for the catalytic oxidation of hydrocarbons |
01/29/2003 | EP1192145A4 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
01/29/2003 | EP1102761B1 Cyclopentabenzofuran derivatives and their use |
01/29/2003 | EP0973735B1 Polyaromatic antiviral compositions |
01/29/2003 | EP0835243B1 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
01/29/2003 | EP0832081B1 Bicyclic-aromatic compounds |
01/29/2003 | EP0817772B1 Pyrrolidinyl hydroxamic acid compounds and their production process |
01/29/2003 | CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists |
01/29/2003 | CN1100055C Piperazine and piperidine compounds |
01/29/2003 | CN1100051C Process for preparation of maleic anhydride |
01/29/2003 | CN1100050C Method for preparing tetrahydrofuran by utilizing dehydration and cyclization of 1,4-butanediol |
01/29/2003 | CN1100049C Method for preparing tetrahydeofuran by dehydrating and cyclization of 1,4-butanediol |
01/28/2003 | US6512140 Cyclization, iminoesterification, hydrolysis, in situ oxidation, sulfiding, cleavage, and purification |
01/28/2003 | US6512127 Process for the preparation of hydroxylactones |
01/28/2003 | US6512126 Process for preparing mint lactone |
01/28/2003 | US6512007 Treatment of inflammatory processes induced by excessive expression of the IL-6-induced acute phase proteins |
01/28/2003 | US6512003 Synthetic spiroketal pyranes as potent anti-cancer agents and use |
01/28/2003 | US6511980 For therapy of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel disorder |
01/28/2003 | US6511976 Having antipsychotic, cardiovascular and gastrokinetic activity |
01/28/2003 | US6511942 Animal husbandry, veterinary medicine |
01/28/2003 | CA2273327C Stabilized ascorbyl compositions |
01/28/2003 | CA2253654C Novel nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor |
01/23/2003 | WO2003006454A2 Heterocyclic carboxamides and their use as fungicides |
01/23/2003 | WO2003006450A2 Phthalide compounds useful in optical recording |
01/23/2003 | WO2003006449A1 Method for the preparation of escitalopram |
01/23/2003 | WO2003006448A1 Process for producing benzofuran derivative |
01/23/2003 | WO2003006447A2 Interaction inhibitors of tcf-4 with beta-catenin |
01/23/2003 | WO2003006446A1 Process for the production of ethers, typically thf |
01/23/2003 | WO2003006445A1 Method for the selective production of tetrahydrofuran by hydrogenating maleic acid anhydride |
01/23/2003 | WO2003006443A2 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy |
01/23/2003 | WO2003006430A1 Taxol enhancer compounds |